🇺🇸 Bacilor in United States

11 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 11

Most-reported reactions

1. Flatulence — 2 reports (18.18%)
2. Abdominal Pain — 1 report (9.09%)
3. Candidiasis — 1 report (9.09%)
4. Constipation — 1 report (9.09%)
5. Culture Stool Positive — 1 report (9.09%)
6. Diarrhoea — 1 report (9.09%)
7. Eyelid Oedema — 1 report (9.09%)
8. Gastrointestinal Disorder — 1 report (9.09%)
9. Gastrointestinal Sounds Abnormal — 1 report (9.09%)
10. Hyperhidrosis — 1 report (9.09%)

Source database →

Frequently asked questions

Is Bacilor approved in United States?

Bacilor does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Bacilor in United States?

Centre Hospitalier Universitaire de Nice is the originator. The local marketing authorisation holder may differ — check the official source linked above.